The global Nicotinamide Phosphoribosyltransferase market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Nicotinamide Phosphoribosyltransferase volume and value at global level, regional level and company level. From a global perspective, this report represents overall Nicotinamide Phosphoribosyltransferase market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Nicotinamide Phosphoribosyltransferase in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Nicotinamide Phosphoribosyltransferase manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Genentech, Inc.
Angelini Group
Calico LLC
FORMA Therapeutics, Inc.
OncoTartis, Inc.
Karyopharm Therapeutics, Inc.
Aurigene Discovery Technologies Limited
...

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Hormone
Lipids
Small Molecule Compounds
Others

Segment by Application
Parkinson's Disease
Acute Lung Injury
Breast Cancer
Others